Akeso

This study tested a new medicine called AK111 in 510 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either AK111 or a placebo to see if the drug could reduce symptoms like pain and improve movement. The ma…

This study tested whether adding the drug AK104 to standard chemotherapy helps people with advanced stomach or gastroesophageal junction cancer live longer. The trial involved 610 adults and compared AK104 plus chemo to a placebo plus chemo. The main goal was to see if the combin…

This study tested a new drug called AK120 in 450 adults with moderate to severe atopic dermatitis (eczema). The main goal was to check for side effects and see how well the drug works. Researchers measured changes in eczema severity using standard skin scores.

This study tested a new drug called AK112 in 40 people with advanced liver cancer that could not be removed by surgery. The drug targets two proteins (PD-1 and VEGF) to help the immune system fight the cancer and cut off its blood supply. The main goals were to see if the drug is…

This study tested a new drug called AK112 in 108 adults with advanced non-small cell lung cancer (stage IIIB/IV) whose tumors had a PD-L1 score of 1% or higher. The drug is a bispecific antibody that targets both PD-1 and VEGF to help the immune system fight cancer and slow tumor…

This study tested a combination of two experimental drugs (AK112 and AK117) with or without chemotherapy in 154 adults with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the combination is safe and can shrink tumors. The drugs work …